Pliant Therapeutics, Inc. (PLRX) Tops Q4 EPS by 17c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.82), $0.17 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AIG (AIG) call put ratio 4 calls to 1 put with a focus on June 26 weekly calls as share price up 3.9%
• Omnicom Media and Netflix partner on AI-powered ad targeting